Mutation analysis and mRNA expression of trail‐receptors in human breast cancer
Open Access
- 12 September 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 102 (2) , 117-128
- https://doi.org/10.1002/ijc.10694
Abstract
The chromosome region 8p12‐p22 shows frequent allelic loss in a variety of human malignancies, including breast cancer (BC). The tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐receptors TRAIL‐R1, ‐R2, ‐R3 and ‐R4 are located on 8p21‐p22 and might be candidate tumor suppressor genes in this region. To evaluate the involvement of TRAIL receptors in breast carcinogenesis, we have analyzed the entire coding region of TRAIL‐R2 and the death domain (DD) regions of TRAIL‐R1 and ‐R4 for the detection of somatic mutations in a series of breast tumors, lymph node metastases and BC cell lines. Overall, we detected 1, 11 and 3 alterations in the TRAIL‐R1, ‐R2 and ‐R4 genes, respectively. Although functional studies have not yet been performed, we assume that most of these alterations do not alter the function of TRAIL‐receptors. Additionally, we analyzed individuals from BC families for the detection of TRAIL‐R2 germline mutations. One alteration has been found in the Kozak consensus motif at position ‐4 with respect to the translation initiation AUG [1‐4 (C→A)]. We further studied the mRNA expression of TRAIL and the 4 TRAIL receptors. In BC cell lines, a strongly decreased mRNA expression of TRAIL, TRAIL‐R1, ‐R3 and ‐R4 was found, whereas the expression of TRAIL‐R2 was only slightly reduced. In breast tumors, a 1.2–3.6‐fold reduction of mRNA signals of the 5 genes was observed. No correlation was found between the expression level of TRAIL and the receptor mRNAs and clinicopathologic variables and between the expression of TRAIL‐R2 and TP53 mutation status and loss of heterozygosity (LOH) at 8p21‐p22. Taken together, we cannot exclude the involvement of TRAIL‐receptors in BC. Our mutation studies indicate that DD receptor mutations occur at low frequency and are not the primary cause for the altered mRNA expression of TRAIL and TRAIL‐receptors in BC.Keywords
This publication has 40 references indexed in Scilit:
- Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parametersEuropean Journal Of Cancer, 2000
- Clinical Significance of Alterations of Chromosome 8 in High-Grade, Advanced, Nonmetastatic Prostate CarcinomaJNCI Journal of the National Cancer Institute, 1999
- Deletion mapping of the tumor suppressor locus involved in colorectal cancer on chromosome band 8p21Genes, Chromosomes and Cancer, 1999
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancerGenes, Chromosomes and Cancer, 1998
- Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinomaOncogene, 1998
- Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesisBritish Journal of Cancer, 1997
- Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancerGenes, Chromosomes and Cancer, 1996
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- A 3‐Mb physical map of the chromosome region 8p21.3‐p22, including a 600‐kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non‐small cell lung cancerGenes, Chromosomes and Cancer, 1994